XinYang

In July 2013, XinYang was established. Its business footprint covers education, science popularization, content, medical devices, and other fields. Its product "XinYang Beauty Micro-plastic Surgery APP" is a search and e-commerce platform providing quality medical and beauty plastic surgery services for global users, committed to using technology to help consumers achieve beauty safely. The product format is "social + content + e-commerce," which is called the "XinYang Model" in the industry. Currently, XinYang's business covers 351 cities in five countries: China, South Korea, Singapore, Japan, and Thailand. It has attracted more than 7,000 regular medical beauty institutions and 25,814 doctors with practicing qualifications to settle in; 25 million users have left traces of search and consumption on the XinYang platform. More than 3.5 million beauty diaries written by consumers and over 330 encyclopedia categories on the platform provide real and effective decision-making auxiliary information. Since 2015, the XinYang APP has been connected with the verification channel of the Health and Family Planning Commission, and launched a strict selection plan, with five guarantees: 100% genuine products, 100% on-site inspection, Oxygen Protection, lightning refund, and advance compensation, to achieve "XinYang once, beauty assured." Since 2016, XinYang has become an overall profitable medical beauty platform. According to monitoring by third-party data companies QuestMobile and Analysys, XinYang accounts for nearly 90% of the launches of medical beauty apps. In December 2017, XinYang announced the completion of a 400 million yuan D-1 round of financing, led by Apax Partners, with joint investment from CDH Investments, and follow-on investment from existing investors Matrix Partners China and Trustbridge Partners, with Taihe Capital serving as the exclusive financial advisor. In 2017, XinYang's online transaction volume exceeded 6 billion yuan, driving an output value of more than 15 billion yuan in the medical beauty industry. In March 2018, only 80 days after the D-1 round, XinYang announced the completion of a 200 million yuan D-2 round of financing, led by Orchid Asia Group Investment, with follow-on investments from Matrix Partners China, Trustbridge Partners, Apax Partners, and CDH Investments. Taihe Capital continued to serve as the financial advisor for this transaction. In September 2018, XinYang completed a US$70 million E-round financing.